Back to results
US 2026/0217652 A1Published application
Phenyl-substituted heteroaryl compound and pharmaceutical composition comprising same, preparation method therefor and use thereof
AssigneeShanghai Meiyue Biotech Development Co., Ltd.
InventorsLinbo LUAN, Nianfeng HUANG, Yuanshan YAO
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a phenyl-substituted heteroaryl compound and a use thereof. Specifically, provided is a phenyl-substituted heteroaryl compound represented by formula (I), which can be used for preparing a drug, especially preparing a drug for preventing and/or treating p38 MAPK MK2 pathway-mediated diseases or disorders. Each group in formula (I) is as defined in the description.
Claims23
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,
- wherein
- ring A is phenyl or 5- to 6-membered heteroaryl;
- each R1 is the same or different, and independently selected from the group consisting of H, halogen, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 hydroxyalkyl, cyano, hydroxyl, amino, nitro, and 3- to 8-membered cycloalkyl;
- R2 is selected from the group consisting of H, halogen, and C1-6 alkyl;
- R3 is selected from the group consisting of H, halogen, C1-6 alkyl, and C1-6 haloalkyl;
- R4 is selected from the group consisting of H, halogen, cyano, hydroxyl, amino, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 hydroxyalkyl, and 3- to 8-membered cycloalkyl;
- R5 is selected from the group consisting of H, halogen, and C1-6 alkyl;
- each R6 is the same or different, and independently selected from the group consisting of H, halogen, cyano, hydroxyl, amino, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 hydroxyalkyl, —C(O)ORe, —C(O)NRgRh, —C(O), —S(O)2Rf, and 3- to 8-membered cycloalkyl;
- R7 is selected from the group consisting of H, halogen,
- —C(O)ORe, —C(O)NRgRh, —C(O)Rf, and —S(O)2Rf;
- RA and RB are the same or different, and each independently selected from the group consisting of H, C1-6 alkyl, or C1-6 haloalkyl;
- R7a and R7b are the same or different, and each independently selected from the group consisting of H, D, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, —C(O)ORe, —C(O)NRgRh, —C(O)f, —S(O)2Rf, and 3- to 8-membered cycloalkyl;
- alternatively, R7a and R7h together with the carbon to which they are attached form a 3- to 8-membered cycloalkyl or 3- to 8-membered heterocyclyl ring, wherein the 3- to 8-membered cycloalkyl or 3- to 8-membered heterocyclyl is optionally substituted by one or more substituents selected from the group consisting of halogen and C1-6 alkyl;
- R7c and R7d are the same or different, and each independently selected from the group consisting of H, D, halogen, cyano, hydroxyl, amino, oxo (═O), C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 hydroxyalkyl, and 3- to 8-membered cycloalkyl;
- alternatively, R7c and R7d together with the carbon to which they are attached form a 3- to 8-membered cycloalkyl or 3- to 8-membered heterocyclyl ring, wherein the 3- to 8-membered cycloalkyl or 3- to 8-membered heterocyclyl is optionally substituted by one or more substituents selected from the group consisting of halogen and C1-6 alkyl;
- Re is selected from the group consisting of H, C1-6 alkyl, C1-6 haloalkyl, and 3- to 8-membered cycloalkyl;
- Rg and Rh are the same or different, and each independently selected from the group consisting of H, C1-6 alkyl, hydroxyl, C1-6 alkoxy, and 3- to 8-membered cycloalkyl, wherein the C1-6 alkyl, C1-6 alkoxy, and 3- to 8-membered cycloalkyl are optionally substituted by one or more substituents selected from the group consisting of halogen, cyano, hydroxyl, amino, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 hydroxyalkyl, and 3- to 8-membered cycloalkyl;
- alternatively, Rg and Rh together with the N to which they are attached form a 3- to 6-membered heterocyclyl ring, wherein the 3- to 6-membered heterocyclyl is optionally substituted by one or more substituents selected from the group consisting of halogen, hydroxyl, C1-6 alkyl, and C1-6 haloalkyl;
- Rf is selected from the group consisting of H, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, and 3- to 8-membered cycloalkyl;
- alternatively, R6 and R7 together with the atom to which they are attached form a 3- to 8-membered heterocyclyl ring, wherein the 3- to 8-membered heterocyclyl is optionally substituted by one or more substituents selected from the group consisting of hydroxyl, oxo, C1-6 alkoxy, C1-6 alkyl, C1-6 haloalkyl, and C1-6 haloalkoxy;
- R8 and R9 are the same or different, and each independently selected from the group consisting of H, D, halogen, C1-6 alkyl, and C1-6 haloalkyl;
- alternatively, R8 and R9 together with the atom to which they are attached form a 3- to 6-membered cycloalkyl ring, wherein the 3- to 6-membered cycloalkyl is optionally substituted by one or more substituents selected from the group consisting of halogen, hydroxyl, C1-6 alkyl, and C1-6 haloalkyl;
- n is selected from the group consisting of 0, 1, 2, 3, and 4;
- m is selected from the group consisting of 0, 1, 2, 3, 4, and 5.
21 more elements
(canceled)
12-16. (canceled)
(canceled)
Dependencies are inferred from the claim text.